FIELD: medicine, phthisiology. SUBSTANCE: method involves the use of complex therapy in combination with betamecil - β--form of methyluracil. Betamecil is administrated orally as tablets or powders, 3 times per a day, or by inhalation or intratracheal route as 0.6-1.2% an aqueous solution, once per a day. Single dose of betamecil is 0.03-0.06 g. EFFECT: enhanced effectiveness of treatment.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PATIENTS WITH CHRONIC FORMS OF PULMONARY TUBERCULOSIS | 2013 |
|
RU2519140C1 |
| METHOD OF TREATING DESTRUCTIVE PULMONARY TUBERCULOSIS | 2010 |
|
RU2450820C2 |
| METHOD OF TREATING PULMONARY AND BRONCHIAL TUBERCULOSIS IN VARIOUS X-RAY SYNDROMES | 2023 |
|
RU2826098C1 |
| PULMONARY TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2195313C1 |
| METHOD OF TREATING FIBROCAVERNOUS TUBERCULOSIS | 0 |
|
SU1803113A1 |
| METHOD OF TREATMENT OF PATIENTS ILL WITH DESTRUCTIVE TUBERCULOSIS OF THE LUNGS | 0 |
|
SU1454464A1 |
| METHOD OF DETERMINING THE TIMING OF SURGICAL INTERVENTION WHEN USING SHORT COURSES OF CHEMOTHERAPY FOR THE TREATMENT OF PULMONARY TUBERCULOSIS | 2022 |
|
RU2798945C1 |
| METHOD OF TREATING PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2015 |
|
RU2587332C1 |
| METHOD FOR DIAGNOSING AND TREATING BRONCHIAL HYPERACTIVITY IN SMOKERS AND NON-SMOKERS WITH PULMONARY TUBERCULOSIS | 2023 |
|
RU2822712C1 |
| METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS MULTIPLE DRUG-RESISTANCE OF TUBERCULOSIS MYCOBACTERIA | 2018 |
|
RU2687743C1 |
